In our continued effort to discover new diterpene glycoside sweeteners from Stevia rebaudiana Bertoni with a better taste profile than that of rebaudioside M, we have isolated three novel steviol glycosides with 9 glucose units, 3 at the C-13 site of the aglycone backbone and 6 at the C-19 site. Compounds 2-4 contain an additional tri-glucosyl unit attached to the C-19 glycoside region of rebaudioside M. For compounds 2 and 3 this unit is attached via the relatively rare 1→6 -glycoside linkage. For compound 4 this additional unit is attached via the uncommon 1→3 -glycoside linkage. In this paper, we describe the complete structure elucidation of novel diterpene glycosides with 9 sugar moieties by NMR ( 1 H, 13 C, COSY, HSQC-DEPT, HMBC, 1D TOCSY, NOESY) and mass spectral data.
Taste and nutrition are key factors in food selection by consumers. Based on results from a 2000 Food Marketing Institute (FMI) survey, consumers consider taste more important than nutrition [1] . Among the five basic human tastes, sweetness is the most pleasant taste to induce food intake regardless of age. The food industry has used sweetness extensively to engage food and beverage consumers. However, excessive intake of sweet food or drink is now considered as a potential source of health issues. Although such issues can be solved by appropriate dietary habits, the food industry has been working on fundamental solutions by investing in research and development of low or no-calorie sweetening additives.
For the past several decades, the sweetener research industry has adopted two basic approaches to the discovery of non-nutritive sweetening agents no-calorie artificial sweeteners and no-calorie natural sweeteners. Currently, five artificial sweeteners are approved in the US; these are aspartame, acesulfame-K, neotame, saccharin and sucralose. A great deal of effort is now focused on the discovery and development of non-calorie high potency sweeteners from natural sources, such as fruits or plants. One of the most advanced non-calorie natural sources of sweeteners is Stevia [2] . Stevia rebaudiana Bertoni is a sweet-tasting herb from the Asteraceae family and originates from northeastern Paraguay. The plant has gained worldwide attention due to its production of zero calorie sweetening compounds. The most abundant constituents in the dry leaves of S. rebaudiana are stevioside and rebaudioside A, known to be up to 400 times sweeter than sucrose [3] . Many other minor components including rebaudioside B -F are also known sweet components in the leaves [4] . Recently, we reported the isolation of a minor Stevia component, rebaudioside M, which has a better taste profile than that of other known steviol glycosides [5] . Most recently, a novel high molecular weight component possessing 9 glucose units attached to a central diterpenoid core and termed rebaudioside IX (1) was isolated [6] . To our knowledge, compound 1 is the first steviol glyoside containing 9 glucose units discovered in our search for novel potential sweetening agents. Herein, we report three additional analogues containing 9 glucose units. In this report, we describe the isolation and structure elucidation of compounds 2, 3 and 4 ( Figure 1 ) based on 1D ( 1 H, 13 C and TOCSY) and 2D (COSY, HSQC-DEPT, HMBC and NOESY) NMR spectral as well as MS studies.
Compound 2 was isolated from a commercial extract of S. rebaudiana as a white solid. Accurate mass measurement using high resolution mass spectrometry (HRMS) provided an exact mass at m/z 1775.6869 in the negative electrospray ionization (ESI)-TOF mass spectrum corresponding to a molecular formula of C 74 H 120 O 48 (calcd. for C 74 H 119 O 48 : 1775.6871). The negative ESI MS/MS spectrum of compound 2 showed sequential loss of four glucose units at m/z 1613. 7109, 1451.6315, 1289.5242, and 1127.4644 followed by the loss of two glucose units at m/z 803.3741 and sequential loss of three glucose units at m/z 641. 3300, 479.2630, and 317.2186 indicating the presence of nine glucose units in the structure. An ion observed at m/z 971.3421 was likely due to cleavage of the ester linkage and subsequent loss of water from one of the six sugar units. NMR experiments including 1 H, 13 C, 1 H-1 H COSY, 1 H-13 C HSQC-DEPT, 1 H-13 C HMBC, 1 H-1 H NOESY, and 1D TOCSY  were performed and extensive analysis of the data allowed  elucidation of the structure of compound 2 (Tables 1 and 2, also see  Supplementary Materials for representative 1D and 2D NMR  spectra) . The 1D and 2D NMR data indicated that the central core of the glycoside was a diterpene. The 1 H NMR spectrum and the HSQC-DEPT data of compound 2 indicated the existence of two methyl singlets at δ 1.41 (C-18) and 1.33 (C-20) , two olefinic proton singlets corresponding to an exocyclic double bond at δ H 4.94 and 5.70 (C-17), nine methylene and two methine protons between δ H 0.71-2.71 characteristic of the ent-kaurane diterpenoid and similar to rebaudioside IX (1) . These assignments were confirmed by 1 H-1 H COSY and 1 H-13 C HMBC correlations ( Figure 2 ). An extensive analysis of 1D and 2D NMR experiments allowed the complete assignments of the protons and carbons of the nine glucose units while the HMBC data allowed determination of the connectivity of the glucose units. The anomeric proton observed at δ H 6.16 showed an HMBC correlation to a carbonyl carbon at δ C 176.8 (C-19) which indicated that it corresponded to the anomeric proton of Glc I (Figure 3) . The COSY and 1D TOCSY data allowed assignments of Glc I H-1 (δ H 6.16), H-2 (δ H 4.49), H-3 (δ H 5.02), H-4 (δ H 4.03), H-5 (δ H 4.22) and H-6 (δ H 4.12 and 4.22). The HSQC-DEPT data then allowed assignment of the carbons as C-1 (δ C 94.4), C-2 (δ C 76.1), C-3 (δ C 87.3), C-4 (δ C 70.7-71.2), C-5 (δ C 77.4), and C-6 (δ C 66.9). These assignments were further confirmed by HMBC correlations of H-1/C-2, C-3; H-2/C-1, C-3; H-3/C-2, C-4; H-4/C-3, C-5, C-6 and H-6/C-4. The higher frequency 1 H and 13 C chemical shifts observed for C-2, C-3 and C-6 positions of Glc I suggested the attachment of glycosyl units at these positions. This was confirmed by HMBC correlations observed from the anomeric protons at δ H 5.71 (Glc V, H-1) to δ C 76.1 (Glc I, C-2); δ H 5.37 (Glc VI, H-1) to δ C 87.3 (Glc I, C-3) and δ H 5.58 (Glc VII, H-1) to δ C 66.9 (Glc I, C-6) and the reciprocal correlations from δ H 4.49 (Glc I, H-2) to δ C 103.3 (Glc V, C-1); δ H 5.02 (Glc I, H-3) to δ C 103.4 (Glc VI, C-1) and δ H 4.22 (Glc I, H-6) to δ C 98.6 (Glc VII, C-1). These results thus established the 2,3,6-O-branched-D-glucotriosyl substituent of Glc I. The 1 H and 13 C NMR assignments for Glc V and Glc VI were done in the same way as that described for Glc I and are presented in Table 2 . The large coupling constants for the anomeric protons of Glc I (δ H 6.16, d, J 3 = 8.2 Hz), Glc V (δ H 5.71, d, J 3 = 8.3 Hz), and Glc VI (δ H 5.37, d, J 3 = 7.9 Hz) indicated their β-configuration while a smaller coupling constant for the anomeric proton of Glc VII (δ H 5.58, d, J 3 = 3.2 Hz) indicated an αconfiguration and thus established a 1→6 α-linkage between Glc VII and Glc I ( Figure 3 ). The 1 H NMR assignments for Glc VII were also established similarly using a combination of COSY and 1D TOCSY data and are given as H-1 (δ H 5.58), H-2 (δ H 4.18), H-3 (δ H 4.66), H-4 (δ H 4.19), H-5 (δ H 4.42), and H-6 (δ H ~4.2 and 4.29). The HSQC-DEPT data was then used to assign the carbons of Glc VII as C-2 (δ C 80.0), C-3 (δ C 83.9), C-4 (δ C 69.7), C-5 (δ C 72.3), and C-6 (δ C 61.5-62.2). The proton and carbon assignments were further confirmed by HMBC correlations of H-1/C-2, C-3, C-5; H-2/C-3; H-3/C-2, C-4; H-5/C-4. The higher frequency 13 C chemical shifts of the C-2 and C-3 positions of Glc VII suggested the attachment of glycosyl units at these positions. This was confirmed by HMBC correlations observed from the anomeric protons at δ H 5.15 (Glc VIII, H-1) to δ C 80.0 (Glc VII, C-2) and δ H 5.14 (Glc IX, H-1) to δ C 83.9 (Glc VII, C-3) as well as the reciprocal correlations from δ H 4.18 (Glc VII, H-2) to δ C 105.4 (Glc VIII, C-1) and δ H 4.66 (Glc VII, H-3) to δ C 104.4 (Glc IX, C-1) thus establishing the 2,3-O-branched-Dglucodiosyl substituent of Glc VII. The 1 H and 13 C chemical shifts of Glc VII H-1/C-1 (δ H 5.15/δ C 105.4, H-2/C-2 (δ H 4.07/δ C 74.8), H-3/C-3 (δ H 4.19/δ C 77.2-77.9), H-4/C-4 (δ H 4.13/δ C 70.7-71.2), H-5/C-5 (δ H 3.86/δ C 77.2-77.9), and H-6/C-6 (δ H 4.28 and 4.45/δ C 61.5-62.2) and Glc IX H-1/C-1 (δ H 5.14/δ C 104.4), H-2/C-2 (δ H 4.00/δ C 74.9), H-3/C-3 (δ H 4.14/δ C 77.2-77.9), H-4/C-4 (δ H 4.10/δ C 70.7-71.2), H-5/C-5 (δ H 3.80/δ C 77.2-77.9) and H-6/C-6 (δ H 4.21 and 4.45/δ C 61.5-62.2) were similarly done based on 1D and 2D NMR data and are summarized in Table 2 .
A series of
The large 3-bond coupling constants for the anomeric protons of Glc VIII (δ H 5.15, d, J 3 = 7.6 Hz) and Glc IX (δ H 5.14, d, J 3 = 7.5 Hz) indicated their β-configuration. Some of the 1 H and 13 C chemical shifts could not be unequivocally assigned due to resonance overlap and, for these, a specific range of values is provided. Thus, the complete 1 H and 13 C assignments of the glycosides attached at C-19 position of the central diterpene core were done based on extensive analysis of 1D and 2D NMR data, and are provided in Table 2 , while the key COSY and HMBC correlations are provided in Figure 3 . The attachment of a six-sugar substituent unit at the C-19 position of the central diterpene core has not been previously reported.
The remaining three sugar units in compound 2 were assigned on the basis of further analysis of the 1D and 2D NMR data. Thus the HMBC correlation from the anomeric proton at δ H 5.43 (δ C 95.8) to a quaternary carbon at δ C 87.7 (C-13) allowed its assignment as the anomeric proton of Glc II (Figure 4) -6 (δ H 4.20 and 4.27) . The HSQC-DEPT data was then used to establish the carbon assignments for C-1 (δ C 95.8), C-2 (δ C 80.5), C-3 (δ C 87.0), C-4 (δ C 69.5), C-5 (δ C 77.2), and C-6 (δ C 61.7). These assignments were further confirmed by HMBC correlations of H-1/C-5; H-2/C-1, C-3; H-3/C-2, C-4; H-4/C-3, C-5, C-6 and H-6/C-4. The higher-frequency 1 H and 13 C chemical shifts of the C-2 and C-3 positions observed in Glc II suggested glycosyl substituents at these positions and these were further confirmed by the following HMBC correlations.
The anomeric proton observed at δ H 5.47 showed an HMBC correlation to Glc II C-2 (δ C 80.5) and was assigned as the anomeric proton of Glc III. The anomeric proton observed at δ H 5.51 showed an HMBC correlation to Glc II C-3 (δ C 87.0) and was assigned as the anomeric proton of Glc IV. The reciprocal HMBC correlations from Glc II H-2 (δ H 4.20) to the anomeric carbon of Glc III (δ C 104.0) and from Glc II H-3 (δ H 4.96) to the anomeric carbon of Glc IV (δ C 103.5) further confirmed these linkages and established the glucodiosyl substituents in Glc II. The 1 H and 13 C NMR assignments for Glc III and Glc IV were established in a similar manner based on the 1D and 2D NMR data. The large 3-bond coupling constants for the anomeric protons of Glc II (δ H 5.43, d, J 3 = 7.6 Hz), Glc III (δ H 5.47, d, J 3 = 8.0 Hz), and Glc IV (δ H 5.51, d, J 3 = 8.0 Hz) indicated their β-configuration. Some 1 H and 13 C chemical shifts could not be unequivocally assigned due to resonance overlap, and for these, a specific range of values is provided. The key COSY and HMBC correlations observed for C-13 glycosides are provided in Figure 4 , and the complete 1 H and 13 C NMR assignments of these sugars are provided in Table 2 . Thus, extensive analysis of the 1D and 2D NMR data established the connectivities of the nine sugars to complete assignments of compound 2. The complete 1 H and 13 C assignments of compound 2 are provided in Tables 1-2.
The structures of compounds 3 and 4 were assigned in the same manner and these compounds were established to be isomers of compound 2 which differ only by the attachment of Glc VII -Glc IX units at different positions (Figure 1) . The 1 H and 13 C chemical shifts of compounds 3 and 4 are summarized in Tables 1 and 2. Their mass spectral data supported the structures for compounds 3 and 4.
In conclusion, NMR and MS analyses allowed full assignments of newly isolated steviol glycosides possessing nine glucose units, compound 2 as ( 
Experimental
General experimental procedures: NMR data were acquired on a Bruker Avance 500 MHz spectrometers with either a 2.5 mm inverse probe or a 5 mm broad band probe and Bruker Avance 600 MHz spectrometer with a 5 mm cryo-probe using ~1.5 ~ 4 mg of compound dissolved in 175-250 µL of either pyridined 5 /TMS+D 2 O (~10:1) or methanol-d 4 /TMS. The 1 H and 13 C NMR spectra were referenced to the TMS signal ( H 0.00 ppm and  C 0.0 ppm) and methanol-d 4 /TMS or methanol-d 4 ( H 0.00 or 3.30 ppm and  C 0.0 or 49.0 ppm). MS and MS/MS data were generated with a Waters Micro QTof mass spectrometer equipped with an electrospray ionization source in negative ion mode. Fractions from secondary and tertiary purification steps were analyzed using the Three steviol glycosides with 9 glucose units Natural Product Communications Vol. 12 (10) 2017 1561 following method: Gradient: 0-5 min (90A:10B), 5 min (70A:30B), 25 min (50A:50B), 2-30 min (90A:10B). The peak for 1 was observed at a retention time (RT) of approximately 19.7 minutes.
LC-MS Analyses:
LC-MS analyses of enhanced fractions were carried out on a AB Sciex API 150EX MS using Turbo Spray with a mass window of 500 -2000 Da using the following method: Phenomenex Synergi Hydro-RP; Column Temp: Ambient; Mobile Phase A: 15% MeCN in water; Mobile Phase B:30% MeCN in water; Gradient: 0-5 min (100A:0B), 5-25 min (0A:100B), 25-30 min (0A:100B), 32 min (100A:0B), Flow Rate: 1.0 mL/min; Injection volume: 10 µL.
Isolation of 2 by Preparative HPLC: The purification was performed in four chromatographic steps. First and third processes used a Waters Symmetry Shield RP18 (50 × 250 mm, 7 µm, p/n WAT248000) column at ambient temperature; Flow rate at 105 mL/min; detection by UV (210 nm), the second step used a Phenomenex Synergi Hydro RP 80 Å (50 × 250 mm, 10 µm, p/n 00G-4376-V0) at ambient temperature, and the fourth step used a Phenomenex Luna C18 (50 × 250 mm, 15 µm, p/n 00G-4273-V0-AX) at ambient temperature; Flow rate at 105 mL/min; detection by UV (210 nm). The primary process used the following method: Mobile Phase A: 15% MeCN in water; Mobile Phase B: 25% MeCN in water; Mobile Phase C: 85% MeCN in water; Gradient: 0-11 min (100A:0B:0C), 12-40 min (0A:100B:0C), 41-51 min (0A:0B:100C), 52 min (100A:0B:0C); Injection load: 12 g of crude dissolved in 40 mL of dimethylsulfoxide (DMSO), then diluted with 120 mL of water with Mobile Phase A. The second chromatographic step used the following method: Mobile Phase A: 18% MeCN in water; Mobile Phase B: 50% MeCN in water; Gradient: 0-75 min (100A:0B), 76-85 min (0A:100B), 86 min (100A:0B); Injection load: 0.5 g in 40 mL of water. The third chromatographic step used the following method: Mobile Phase A: 40% MeOH in water with 0.0028% NH 4 OAc and 0.012% HOAC; Mobile Phase B: 50% MeCN in water; Gradient: 0-45 min (100A:0B), 46-55 min (0A:100B), 56 min (100A:0B); Injection load: 0.05 g in 20 mL of water. The fourth process used the following method: Mobile Phase A: 5% MeCN in water; Mobile Phase B: 21% MeCN in water; Mobile Phase C: 50% MeCN in water; Gradient: 0-10 min (100A:0B:0C), 11-30 min (0A:100B:0C), 31-40 min (0A:0B:100C), 41 min (100A:0B:0C); Injection load: 25 mL of concentrate. The isolated compound was recovered from the eluent via rotary evaporation. The aqueous solution was pre-concentrated using a solid phase extraction (SPE) cartridge, further concentrated via rotary evaporation, and then lyophilized (FTS System benchtop lyophilizer). Purity of the final product was >99% as confirmed by LC-CAD. Approximately 4.4 mg of 2 was provided for spectroscopic and spectrometric analyses.
( 13-[(2-O-β-D-glucopyranosyl-3-O-β-D-glucopyranosyl)-β-Dglucopyranosyl)oxy] ent-kaur-16-en-19-oic acid-[(2-O-β-Dglucopyranosyl-3-O-β-D-glucopyranosyl-6-O-α-D-glucopyranosyl-(2-O-β-D-glucopyranosyl-3-O-β-D-glucopyranosyl) -β-Dglucopyranosyl) ester] (2) Amorphous white powder (4.4 mg, purity >99%) 1 H NMR (500 MHz, pyridine-d 5 +D 2 O): Table 1 and 2 13 C NMR (125 MHz, pyridine-d 5 +D 2 O): Table 1 Table 1 and 2 13 C NMR (150 MHz, MeOD-d 4 ): Table 1 Table 1 and 2 13 C NMR (150 MHz, MeOD-d 4 ): Table 1 Supplementary data: 1D, 2D NMR spectra, HPLC profiles, MS spectra and isolation methods for compounds 2, 3 and 4 are provided in the supporting information.
